Oregon Public Employees Retirement Fund’s Krystal Biotech KRYS Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.54M	Buy	5,949 +53	+0.9%	+$14.1K	0.02%	639
2025 Q4	$1.45M	Buy	5,896 +57	+1%	+$12K	0.02%	654
2025 Q3	$1.03M	Buy	5,839 +37	+0.6%	+$5.54K	0.01%	832
2025 Q2	$798K	Hold	5,802	–	–	0.01%	901
2025 Q1	$1.05M	Sell	5,802 -173	-3%	-$29.1K	0.02%	739
2024 Q4	$936K	Sell	5,975 -5	-0.1%	-$887	0.02%	834
2024 Q3	$1.09M	Sell	5,980 -50	-0.8%	-$9.64K	0.02%	764
2024 Q2	$1.11M	Buy	+6,030	New	+$1.01M	0.02%	710

Other funds holding KRYS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oregon Public Employees Retirement Fund's KRYS Position: Q1 2026 in Review

Oregon Public Employees Retirement Fund increased its Krystal Biotech (KRYS) stake by 0.9% in Q1 2026, buying an estimated $14.1K and bringing the position to 5,949 shares worth $1.54M. The position accounts for 0.02% of the portfolio, ranked #639.

Oregon Public Employees Retirement Fund first reported a position in KRYS in Q2 2024 and has held it in 8 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

Oregon Public Employees Retirement Fund held 5,949 shares of Krystal Biotech worth $1.54M as of Q1 2026.
Oregon Public Employees Retirement Fund bought 53 Krystal Biotech shares in Q1 2026, an estimated $14.1K.
Krystal Biotech made up 0.02% of Oregon Public Employees Retirement Fund's portfolio in Q1 2026, its #639 holding.
Oregon Public Employees Retirement Fund first reported a position in Krystal Biotech in Q2 2024 and has held it in 8 quarters since.
367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q1 2026, filed 29 Apr 2026.